Last week, @ASCO's @jrgralow joined experts to testify on pervasive US #DrugShortages and the devastating impact on cancer patients, their families, and communities. #Repost her powerful words ⤵️ and learn more about our collective call for action: https://t.co/KvCgo08YDV
@jrgralow .@jrgralow shares the story of a pt in TX whose metastatic breast cancer was responding well to carboplatin. B/c of #drugshortages, the use of carboplatin was discontinued, and the pt's cancer has progressed. Urge Congress to act! https://t.co/OQL0kWRy2L #ASCOAdvocacy
.@jrgralow is testifying before the Ways & Means Committee, urging Congress to end #DrugShortages. Providers are being forced to make impossible choices & patients are being harmed in the process. Tell your Representative to make changes! https://t.co/lanBA09Vz2 #ASCOAdvocacy
I was honored to represent @ASCO on Capitol Hill where I testified “we have life saving drugs and life threatening shortages”. Please click below to tell Congress to this matters.
Wow! 👀 @GMA talked about cancer drug shortages this morning, including my testimony for @ASCO to @SenateFinance. “We have life saving drugs and life threatening shortages” Tell Congress to act: ⬇️
I am proud that the “Physician Fee Schedule Update and Improvements Act” passed out of the @HouseCommerce committee.
Read more here: https://t.co/bSs3GWFicv
Thank you @RonWyden & @MikeCrapo and @SenateFinance
for the important hearing today on drug shortages. On behalf of @ASCO, I testified “we have life saving drugs, and life threatening shortages”
Today @Lymphoma_Doc is testifying before the Senate Finance Committee addressing #DrugShortages from an oncologist’s point of view. Tune in at 10 AM ET: https://t.co/SrehDqPMMU #ASCOAdvocacy
"My patients, and their families, deserve to know that they will get the care they need without delay" -@Lymphoma_Doc in testimony to the Senate Finance Committee on the ongoing #drugshortages crisis.
Tell Congress to take action NOW: https://t.co/zvO8Rlr8dY #ASCOAdvocacy
This week we’re calling attention to the continued #drugshortage crisis and working to inform policymakers of the deeply distressing circumstance patients are facing.
Learn more and tell Congress to act now: https://t.co/EnmF11Bnnj #ASCOAdvocacy#OncTwitter
Amazing to see: Top leadership roles at @theNCI@NIH@ASCO@NCCN@AACR@AmericanCancer @LLSResearch & many other orgs are now held by inspiring women! Their exceptional leadership is a testament to the progress and empowerment in global health and their pioneering efforts in improving all our lives 👏 #WomenInLeadership #HealthcareHeroes
👏#ASCOAdvocacy applauds @EnergyCommerce & @HouseCommerce as they work together to advance necessary policy to reform Medicare physician reimbursement. Our most recent statement on Medicare payment: https://t.co/vlcrv6wEhT
⚕️Health care advocacy is skill not often taught in fellowship yet critical to our mission of improving the lives of our patients.
🚨Read more about how @DrBrianPersing is making an impact in his state & at the national level. #ASCOAdvocacySummit
➡️Link: https://t.co/wNS3FoBvUV
Congratulations to Dr. Monica Bertagnolli on her confirmation as @NIH Director. A truly extraordinary leader for this role. Looking forward to ongoing collaboration with the NIH.
#ASCOAdvocacy strongly supports the Palliative Care & Hospice Education & Training Act, which will help bring additional education, training & awareness for patients in need of #palliativecare, including those w/ cancer. We urge lawmakers to cosponsor #PCHETA today! @PatientQoL
#ASCOAdvocacy is pleased to see draft policy addressing #drugshortages from Chair @cathymcmorris. Pts w cancer need timely treatment, & we are eager to work w @HouseCommerce to address this complex issue https://t.co/n2Nbmvq79Y
#DrugShortages Update for Cisplatin:
⚠️ Apotex/Qilu has 10 batches available. Call: 800-706-5575
⚠️ FDA-approved manufacturer, Gland Pharma Limited, will have a new supply starting the 3rd week of July, from their distributor, Sagent. Call: 866-625-1618